top of page

PT-141 — Neuro-Arousal Peptide

Libido signaling • Dopamine activation • Sexual function pathways

PT-141 (Bremelanotide) is a synthetic peptide derived from melanocortin biology that works directly on the central nervous system rather than the vascular system. Unlike traditional compounds that increase blood flow, PT-141 activates melanocortin receptors in the brain, stimulating the pathways responsible for sexual arousal, desire, and performance signaling.

This makes PT-141 unique — it enhances desire first, then physical response follows.

In research and clinical environments, PT-141 has demonstrated potential to support:

Increased sexual desire (libido)
Improved arousal response
Enhanced sensitivity and pleasure signaling
Improved erectile and female sexual function
Central dopamine pathway activation

PT-141 is studied in both male and female sexual dysfunction research, making it one of the only peptides with bi-gender applicability.

Why PT-141 is different

PT-141 does not force blood flow —
it turns on the brain’s desire circuit.

By activating melanocortin receptors (MC3 & MC4), it allows the body to:

• Increase sexual motivation
• Enhance neural arousal signals
• Improve physical response
• Restore libido diminished by stress, aging, or medication

This makes it a powerful compound in neurosexual and hormonal performance research.

Used in research to study

• Hypoactive sexual desire disorder
• Erectile dysfunction
• Female sexual dysfunction
• Dopamine and reward pathways
• Neuro-hormonal signaling

PHP™ Research Performance Standard

Our PT-141 is supplied as a research-grade lyophilized peptide produced in GMP-certified facilities and verified for:

✔ Identity
✔ Purity
✔ Potency
✔ Endotoxin levels

Because performance begins in the brain.
Pure Science. Raw Power.

PT-141 10mg

$30.00Price
Quantity
  • Important Notice

    This product is for laboratory research and development use only.
    Not for human or veterinary use.
    Not intended to diagnose, treat, cure, or prevent any disease.

bottom of page